• Journal of Nutrition and Health
• /
• 제40권8호
• /
• pp.693-700
• /
• 2007

This study was performed to investigate the effects of genistein, a kind of soy isoflavones, on fatty liver and lipid metabolism in rats fed high fat diet. Twenty four male Sprague-Dawley rats were divided into four groups by dietary fat and genistein contents then raised for six weeks. The rats(n=6/group) were fed normal fat diet(NOR), high fat diet (HF), high fat with 0.1% genistein(HF+0.1%G) or high fat with 0.2% genistein(HF+0.2%G). Hepatic total lipid, triglyceride, total cholesterol and Serum GPT, as a marker for fatty liver, were significantly increased by high fat diet. Also, serum total lipid, triglyceride, total cholesterol, glucose and insulin concentration, hepatic lipogenic enzyme (fatty acid synthase and malic enzyme) activities were significantly increased by high fat diet. However, hepatic total lipid, triglyceride, total cholesterol and Serum GPT were significantly decreased by genistein intake. Also, genistein supplementation decreased serum total lipid, triglyceride, glucose and insulin concentration, hepatic lipogenic enzyme (fatty acid synthase and malic enzyme) activities. There were no differences by genistein level except for serum insulin. These results suggest that fatty liver induced by high fat diet was caused by increased serum lipid profiles and hepatic lipogenesis, whereas, genistein may be useful in inhibiting of fatty liver by reducing serum lipid profiles and hepatic lipogenesis.

• International Journal of Oral Biology
• /
• 제37권4호
• /
• pp.189-195
• /
• 2012

Resistance to the induction of apoptosis is a possible mechanism by which tumor cells can survive anti-neoplastic treatments. Melanoma is notoriously resistant to anti-neoplastic therapy. Previous studies have demonstrated focal adhesion kinase (FAK) overexpression in melanoma cell lines. Given its probable role in mediating resistance to apoptosis, many researchers have sought to determine whether the downregulation of FAK in melanoma cells would confer a greater sensitivity to anti-neoplastic agents. Genistein is a known inhibitor of protein-tyrosine kinase (PTK), which may attenuate the growth of cancer cells by inhibiting the PTK-mediated signaling pathway. This present study was undertaken to investigate the effect of genistein on the expression of FAK and cell cycle related proteins in the G361 melanoma cell line. Genistein was found to have a preferential cytotoxic effect on G361 melanoma cells over HaCaT normal keratinocytes. Genistein decreased the expression of 125 kDa phosphotyrosine kinase and the FAK protein in particular. Genistein treatment did not affect the expression of p53 in G361 cells in which p21 is upregulated. The expression of cyclin B and cdc2 was downregulated by genistein treatment. Taken together, our data indicate that genistein induces the decreased proliferation of G361 melanoma cells via the inhibition of FAK expression and regulation of cell cycle genes. This suggests that the use of genistein may be a viable approach to future melanoma treatments.

• KSBB Journal
• /
• 제14권4호
• /
• pp.490-494
• /
• 1999

보조용매가 포함되지 않은 초임계이산화탄소를 이용하여 추출한 결과 온도 및 압력, 유속 등을 변경시켜도 genistein은 추출되지 않았다. 유기용매로 soaking한 결과를 보면 1mL ethanol로 soaking한 경우, 7.8%의 추출수율을 보였으며 함량도 약 7.8%정도를 나타내었다. Methanol로 soaking한 경우 더 낮은 수율과 함량을 보였다. 보조용매가 포함되지 않은 초임계이산화탄소로 추출한 결과 추출이 되지 않아서 보조용매를 이용하였다. 동일한 온도 압력 하에서 추출한 결과를 보면, ethanol이 methanol보다 효과가 우수하였다. 보조용매를 이용할 때 온도의 영향은 ethanol을 보조 용매로 사용한 경우, 압력 300bar일 때에 75$^{\circ}C$에서 56.4%의 최대수율을 나타내었고 함량은 55$^{\circ}C$일 때가 가장 높았다. 온도 35$^{\circ}C$조건에서 9%의 ethanol을 보조용매로 사용하여 압력의 영향을 조사하였다. 그 결과 300bar에서 genistein은 48.1%의 추출 수율을 얻을 수 있었다. 함량은 200bar일 때가 가장 높았지만 300bar와 비교해서 큰 차이가 없었다. 또한 ethanol을 보조용매로 사용할 때 초임계이산화탄소 유량에 대한 영향은 유량이 증가할수록 추출량도 증가하는 경향을 보였으며 함량도 약간 증가하였다. 온도 35$^{\circ}C$, 압력 275bar에서 ethanol 농도의 영향을 조사하였다. ethanol의 농도가 증가할수록 추출량도 증가하였으나 19%이후부터는 증가율이 둔화되었다. 보조용매를 첨가한 초임계유체를 이용하여 genistein을 추출하였을 때에 ethyl ether를 사용하여 추출했을 때와 비교해서 35$^{\circ}C$, 300bar, 30분간의 추출에서 genistein은 71% 추출수율과 31.5%의 함량을 나타내었다.

• Clinical and Experimental Reproductive Medicine
• /
• 제40권2호
• /
• pp.60-66
• /
• 2013

Objective: Impairment of spermatogenesis has been identified as an inevitable side effect of cancer treatment. Although estrogen treatment stimulates spermatogenic recovery from the impaired spermatogenesis by suppressing the intra-testicular testosterone (ITT) level, side effects of estrogen are still major impediments to its clinical application in humans. Soybeans are rich in genistein, which is a phytoestrogen that binds to estrogen receptors and has an estrogenic effect. We investigated the effects of genistein administration on ITT levels, testis weight, and recovery of spermatogenesis in rats treated with a chemotherapeutic agent, busulfan. Methods: Busulfan was administered intraperitoneally to rats, and then a GnRH agonist was injected subcutaneously into the back, or genistein was administered orally. Results: The weight of the testes was significantly reduced by the treatment with busulfan. The testis weight was partially restored after busulfan treatment by additional treatment with either the GnRH agonist or genistein. Busulfan also induced atrophy of a high percentage of the seminiferous tubules, but this percentage was decreased by additional treatment with either the GnRH agonist or genistein. Treatment with genistein was effective at suppressing and maintaining ITT levels comparable to that in the GnRH agonist group. Conclusion: Genistein effectively suppressed ITT levels and stimulated the recovery of spermatogenesis in rats treated with a chemotherapeutic drug. This suggests that genistein may be a substitute for estrogens, for helping humans to recover fertility after cancer therapy without the risk of side effects.

• 한국미생물·생명공학회지
• /
• 제36권1호
• /
• pp.72-81
• /
• 2008

제니스테인의 미백제로서 응용 가능성을 알아보기 위해 멜라닌 생성에 미치는 영향을 in vitro 및 in vivo 실험을 통해 알아보았다. Melan-a 세포에 제니스테인을 처리하여 멜라닌 양을 측정한 결과 멜라닌 생성이 농도 의존적으로 감소되었다. 멜라닌 생성 억제가 tyrosinase의 활성 저해와 관련되는지를 확인해보고자 하였다. 그 결과 제니스테인은 tyrosinase에 직접 작용하여 활성을 저해하지는 않았으나, 세포내의 tyrosinase의 활성은 농도 의존적으로 저해하였다. 제니스테인이 tyrosinase의 발현에는 영향을 미치지 않았는데 이는 세포내 tyrosinase의 활성 저해가 발현과는 다른 기전에 의해 일어난다는 것을 의미한다. 그리고 제니스테인은 ${\alpha}$-glucosidase를 저해하였으며, 이를 통해 N-linked glycoprotein인 tyrosinase의 glycosylation을 저해하여 tyrosinase의 세포내 이동이나 활성을 억제할 수 있음을 알 수 있었다. 또한 제니스테인은 brown guinea pig에서 자외선에 의해 유도되는 피부흑화를 농도 의존적으로 개선하는 미백 효과가 있었다. 인공색소반에 제니스테인을 1%, 2% 도포한 결과 5주차에 대조군과 비교하여 유의적인 미백 효과를 확인할 수 있었다. 멜라닌에 대한 F-M 염색 결과를 살펴보면, 제니스테인 2%를 도포한 부위의 멜라닌 함량이 대조군 도포 부위에 비해 상당히 감소하였음을 확인할 수 있었다. 이상의 결과에서 제니스테인은 미백제로서 유용하게 활용할 가치가 있는 것으로 사료된다.

• Biomolecules & Therapeutics
• /
• 제25권4호
• /
• pp.452-459
• /
• 2017

In this study, the effect of particle size of genistein-loaded solid lipid particulate systems on drug dissolution behavior and oral bioavailability was investigated. Genistein-loaded solid lipid microparticles and nanoparticles were prepared with glyceryl palmitostearate. Except for the particle size, other properties of genistein-loaded solid lipid microparticles and nanoparticles such as particle composition and drug loading efficiency and amount were similarly controlled to mainly evaluate the effect of different particle sizes of the solid lipid particulate systems on drug dissolution behavior and oral bioavailability. The results showed that genistein-loaded solid lipid microparticles and nanoparticles exhibited a considerably increased drug dissolution rate compared to that of genistein bulk powder and suspension. The microparticles gradually released genistein as a function of time while the nanoparticles exhibited a biphasic drug release pattern, showing an initial burst drug release, followed by a sustained release. The oral bioavailability of genistein loaded in solid lipid microparticles and nanoparticles in rats was also significantly enhanced compared to that in bulk powders and the suspension. However, the bioavailability from the microparticles increased more than that from the nanoparticles mainly because the rapid drug dissolution rate and rapid absorption of genistein because of the large surface area of the genistein-solid lipid nanoparticles cleared the drug to a greater extent than the genistein-solid lipid microparticles did. Therefore, the findings of this study suggest that controlling the particle size of solid-lipid particulate systems at a micro-scale would be a promising strategy to increase the oral bioavailability of genistein.

• Food Science and Biotechnology
• /
• 제17권5호
• /
• pp.1021-1024
• /
• 2008

Genistein, one of the isoflavones in doenjang, is generally known to prevent various cancers, osteoporosis, climacterium, and menopause symptoms, and has better bioavailability and healthful physiological effects than its glucoside, genistin. In both traditional and commercial doenjangs, genistein content ranged from 370 to 1,510 mg/kg, however, significant amounts of genistin also existed at the level of 190 to 350 mg/kg. After treating with corn $\beta$-glucosidase, over 84% of genistin in doenjang was converted to genistein. However, physiochemical characteristics such as pH, viscosity, 2-thiobarbituric acid (TBA) value, and color were not changed significantly after corn $\beta$-glucosidase treatments. Therefore, this study shows that the improved doenjang with the increased genistein content can be produced using corn $\beta$-glucosidase.

• Asian-Australasian Journal of Animal Sciences
• /
• 제21권8호
• /
• pp.1220-1225
• /
• 2008

This study was conducted to investigate the protective effect of genistein on the antioxidative defence system and membrane fluidity in chick skeletal muscle cells after supplementation with 0, 20, 40, and $80{\mu}mol/L$ genistein in $50{\mu}mol/L$ $FeSO_4/H_2O_2$ treated cells for 24 h. Genistein supplementation recovered the decreased activity of total superoxide dismutase induced by $FeSO_4/H_2O_2$, significantly increased glutathione peroxidase activity (p<0.05) and decreased malondialdehyde production (p<0.05). The treatment of 80 mol/L genistein in $FeSO_4/H_2O_2$ treated cells decreased the secretion of creatine kinase (p<0.05). Fluorescence polarization values and microviscosities observed with $FeSO_4/H_2O_2$ treated cells were significantly higher than those observed with no $FeSO_4/H_2O_2$ treated cells. The addition of $80{\mu}mol/L$ genistein improved the increased fluorescence polarization value (p<0.05) caused by $FeSO_4/H_2O_2$ treatment. The microviscosity value was significantly decreased by adding genistein (p<0.05). In conclusion, genistein protected skeletal muscle cells from oxidative damage by improving antioxidative status and membrane fluidity.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권2호
• /
• pp.759-764
• /
• 2013

Background: The high recurrence rate after hepatic resection in hepatocellular carcinoma (HCC) is a major obstacle to improving prognosis. The objective of the present study was to explore the function of genistein, a soy-derived isoflavone, in enhancing the inhibitory effect of cisplatin on HCC cell proliferation and on tumor recurrence and metastasis in nude mice after curative hepatectomy. Methods: Proliferation of human HCC cells (HCCLM3) was detected by 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay. Synergistic effects of genistein and cisplatin were evaluated with the median-effect formula. Nude mice bearing human HCC xenografts underwent tumour resection (hepatectomy) 10 days post implantation, then received intraperitoneal administration of genistein or cisplatin alone or the combination of the two drugs. 33 days after surgery, recurrent tumours and pulmonary metastasis were evaluated individually. MMP-2 level in recurrent tumours was detected by immunohistochemistry and real-time PCR; MMP-2 expression in HCCLM3 was detected by immunocytochemistry. Results: Genistein and cisplatin both suppressed the growth and proliferation of HCCLM3 cells. The two drugs exhibited synergistic effects even at relatively low concentrations. In vivo, mice in the combined genistein and cisplatin group had a smaller volume of liver recurrent tumors and fewer pulmonary metastatic foci compared with single drug treated groups. Cisplatin upregulated the expression of MMP-2 in both recurrent tumours and HCCLM3, while genistein abolished cisplatin-induced MMP-2 expression. Conclusions: Genistein reinforced the inhibitory effect of cisplatin on HCC cell proliferation and tumour recurrence and metastasis after curative hepatectomy in nude mice, possibly through mitigation of cisplatin-induced MMP-2 upregulation.

• The Korean Journal of Physiology and Pharmacology
• /
• 제21권6호
• /
• pp.579-589
• /
• 2017

Anesthetics are used extensively in surgeries and related procedures to prevent pain. However, there is some concern regarding neuronal degeneration and cognitive deficits arising from regular anesthetic exposure. Recent studies have indicated that brain-derived neurotrophic factor (BDNF) and cyclic AMP response element-binding protein (CREB) are involved in learning and memory processes. Genistein, a plant-derived isoflavone, has been shown to exhibit neuroprotective effects. The present study was performed to examine the protective effect of genistein against isoflurane-induced neurotoxicity in rats. Neonatal rats were exposed to isoflurane (0.75%, 6 hours) on postnatal day 7 (P7). Separate groups of rat pups were orally administered genistein at doses of 20, 40, or 80 mg/kg body weight from P3 to P15 and then exposed to isoflurane anesthesia on P7. Neuronal apoptosis was detected by TUNEL assay and FluoroJade B staining following isoflurane exposure. Genistein significantly reduced apoptosis in the hippocampus, reduced the expression of proapoptotic factors (Bad, Bax, and cleaved caspase-3), and increased the expression of Bcl-2 and Bcl-xL. RT-PCR analysis revealed enhanced BDNF and TrkB mRNA levels. Genistein effectively upregulated cAMP levels and phosphorylation of CREB and TrkB, leading to activation of cAMP/CREB-BDNF-TrkB signaling. PI3K/Akt signaling was also significantly activated. Genistein administration improved general behavior and enhanced learning and memory in the rats. These observations suggest that genistein exerts neuroprotective effects by suppressing isoflurane-induced neuronal apoptosis and by activating cAMP/CREB-BDNF-TrkB-PI3/Akt signaling.